PLASMA BIOMARKERS FOR ALZHEIMER’S DISEASE AND RELATED NEUROPATHOLOGY IN RELATION TO MCI AND DEMENTIA: THE ARIC STUDY
Kevin Sullivan, Chad Blackshear, Keenan Walker, Michelle Mielke, B Gwen Windham, Michael Griswold, Thomas Mosley, Priya Palta · 2023
Read PLASMA BIOMARKERS FOR ALZHEIMER’S DISEASE AND RELATED NEUROPATHOLOGY IN RELATION TO MCI AND DEMENTIA: THE ARIC STUDY by Kevin Sullivan, Chad Blackshear, Keenan Walker, Michelle Mielke, B Gwen Windham, Michael Griswold, Thomas Mosley, Priya Palta (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10738291.txt.
Description
Eight authors, led by Kevin Sullivan, test in 2023 whether blood markers can flag Alzheimer's disease and related brain harm in older adults. Four markers track sticky protein build up, cell damage, and swelling in the brain. Cheap blood tests for them could change how risk is watched in clinics.
Samples came from over seventeen hundred people in a long running heart and health study, drawn in their mid seventies. Each person was tracked for about six years for mild memory loss, dementia, or death. The team weighed each marker against those outcomes, with health traits held fair. The work helps judge which markers earn a place in care.
Catalog record
| CREATOR | Kevin Sullivan, Chad Blackshear, Keenan Walker, Michelle Mielke, B Gwen Windham, Michael Griswold, Thomas Mosley, Priya Palta |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |